Synvista Therapeutics to Present at Acumen BioFin Rodman & Renshaw 9th Annual Healthcare ... ( -Presentation...)

Synvista Therapeutics to Present at Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference

Date:10/30/2007

-Presentation to be Webcast-

MONTVALE, N.J., Oct. 30 /PRNewswire-FirstCall/ -- Synvista Therapeutics, Inc. (Amex: SYI) announced today that Noah Berkowitz, M.D., Ph.D. President and Chief Executive Officer of Synvista will present at the upcoming Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference on Tuesday, November 6, 2007 at 3:20 p.m. Eastern Time. The event will be held from November 5-7, 2007 at the New York Palace Hotel in New York.

Dr. Berkowitz will discuss the company's planned and/or ongoing Phase 2 initiatives for ALT-2074 in cardiovascular diseases, and alagebrium in heart failure and diabetic nephropathy. He will also provide an update of recent milestones and executive appointments.

The presentation will be simultaneously webcast and can be viewed live on the investor relations section of the Company's website at http://www.synvista.com. Participants are encouraged to log on to the webcast approximately five to ten minutes prior to the start of the presentation. It will be archived there after the event.

Note to Attendees: Synvista will be available for one-on-one meetings. Please arrange through Acumen BioFin Rodman & Renshaw or by calling Emmanuelle Ferrer or Kim Sutton Golodetz at Lippert/Heilshorn & Associates at 212-838- 3777.

The conference will feature presentations from more than 350 public and privately held emerging growth healthcare companies presenting data on an array of therapeutic topics including oncology, cardiovascular disease, central nervous system disorders, infectious diseases and medical device technology. Details regarding the conference can be obtained at

SOURCE Synvista Therapeutics, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3
Related medicine news :

1. VBI Provides Potential Targets to Diabetes Therapeutics
2. CELL THERAPEUTICS PAYS Heavily to Resolve Dispute FOR ALLEGED ILLEGAL MARKETING OF CANCER DRUG
3. Surgeons Presented Guidelines For Postoperative Atrial Fibrillation
4. Researchers Present Ways To Reduce The Risk Of Dementia
5. Researchers Present Data Regarding The Efficiency Of Herbs
6. Critically Ill Patients More At Risk Of Infection If Glucose Is Present In Their Lung Secretions
7. Ovarian Cancer Presents ‘Target Symptoms’ Six Months Before Diagnosi
8. Drug Reactions First Present Themselves In The Mouth
9. Reminiscing Into The Past Makes You Dissatisfied With The Present
10. Living In The Past Indicates Dissatisfaction With Present
11. Movies Represent Coma In A Wrong Way

Post Your Comments:

(Date:6/19/2013)... Mesothelioma Victims Center says, "According to the ... citizens, who will be diagnosed with a rare form ... will be US Navy Veterans. We can assure a ... of cancer, or their family members that we will ... mesothelioma compensation settlement attorneys, who actually do have a ...

(Date:6/19/2013)... Faith4Kidz is starting a new fundraising effrt ... would like help showing support for kids to learn how ... positive. Check out the website, http://www.gracenfaith.com to see ... red, white and blue stars as a symbol of our ... as well as the stars we should encourage our children ...

(Date:6/18/2013)... Exposed Skin Care has finally been released after much ... ages finally achieve the clear, beautiful skin they have always ... clearing system combines the power of science and nature to ... , After a quick review of Exposed ... the most effective available on the market to cure acne ...

(Date:6/18/2013)... South Africa (PRWEB) June 19, 2013 Looking ... disillusionment and monotony of everyday life? , IWALKAWAKE is ... awakening process. Written by Adam Botha, it focuses on harnessing ... , The book lays out a nine-step guide to ... a process that a person must go through to reach ...

(Date:6/18/2013)... York (PRWEB) June 19, 2013 The ... understanding and unprecedented access to the drug delivery partnering ... healthcare companies. , The report provides a detailed ... drug delivery partnering deals. The majority of deals are ... right or an option right to license the license ...

Breaking Medicine News(10 mins):Health News:Mesothelioma Victims Center Urges US Navy Veterans Diagnosed With Mesothelioma To Call Them For Instant Access To The Nation's Top Asbestos Lawyers-Better Compensation 2 Health News:Mesothelioma Victims Center Urges US Navy Veterans Diagnosed With Mesothelioma To Call Them For Instant Access To The Nation's Top Asbestos Lawyers-Better Compensation 3 Health News:Faith4Kidz Introduces Patriotic Hats to Benefit the "Grace in Faith Equals Peace" Mission 2 Health News:Exposed Skin Care Review Released by ExposedSkinCareReview.org 2 Health News:Exposed Skin Care Review Released by ExposedSkinCareReview.org 3 Health News:New Drug Delivery Partnering Terms and Agreements Market Study Report Available at MarketResearchReports.Biz 2 Health News:New Drug Delivery Partnering Terms and Agreements Market Study Report Available at MarketResearchReports.Biz 3 Health News:New Drug Delivery Partnering Terms and Agreements Market Study Report Available at MarketResearchReports.Biz 4

[0] Mesothelioma Victims Center Urges US Navy Veterans Diagnosed With Mesothelioma To Call Them For Instant Access To The Nation's Top Asbestos Lawyers-Better Compensation [0] Faith4Kidz Introduces Patriotic Hats to Benefit the "Grace in Faith Equals Peace" Mission [0] Exposed Skin Care Review Released by ExposedSkinCareReview.org [0] Learn How To Stop Sleepwalking Through Life in New Book 'IWALKAWAKE'[0] New Drug Delivery Partnering Terms and Agreements Market Study Report Available at MarketResearchReports.Biz

... The Institute for Health Freedom (IHF) is warning the ... government to plan for each American to use "an" ... or patient-consent provisions."Congress needs to add opt-out and patient-consent ... IHF president. "The bottom line is that if YOU ...

... Full Value,Committee announced today that it has filed ... materials and is commencing,distribution of those soliciting materials ... ) ("LCAV") to solicit consents to replace the ... highly qualified nominees. The Full,Value Committee,s director ...

... 9 Team Health Inc.,s,parent company, Team Finance LLC ... fiscal year and the fourth quarter ended,December 31, 2008. ... for uncollectibles ("revenue less provision"),for the fiscal year ended ... billion in the prior year. Same contract revenue less ...

... Powerful opioid drugs can pose risks even for patients, ... The U.S. Food and Drug Administration announced plans Monday ... painkillers by requiring manufacturers of certain opioid drugs to ... with the medications. , The FDA said it has ...

... genes can be used to reliably identify the four ... at Washington University School of Medicine in St. Louis ... potentially predict the most effective therapy for each breast ... all patients., "Unlike a widely used genomic test that ...

... adolescent use of prescription pain relievers has dropped, report ... of prescription painkillers among young adults increased from 4.1 ... government report released Monday shows. , However, the researchers ... (SAMHSA) also found that non-medical use of painkillers by ...

Economic Stimulus Bill Mandates Electronic Health Records for Every American by 2014 - With No Opt-out Provision The LCA-Vision Full Value Committee Commences Consent Solicitation to Elect New Board of Directors at LCA-Vision (Nasdaq: LCAV) and Sends Letter to Stockholders Team Finance LLC Announces Fiscal 2008 Financial Results FDA Seeks Better Regulation of Painkillers New genomic test can personalize breast cancer treatment Painkiller Abuse Increases Among Young Adults

(Date:6/18/2013)... , June 18, 2013 Decision Resources, ... firms for pharmaceutical and healthcare issues, announces that ... of the Middle East ... Tracker analyzes the challenges and opportunities to gaining ... international regions comprising 24 countries. The countries covered ...

(Date:6/18/2013)... , June 18, 2013 New-generation ... being highly portable and lightweight. Simultaneously, circuitry is ... the processing speed to which it performs at. ... medical electronics and military equipment, such as cameras ... Omnetics, micro-circular and nano-circular connectors include custom cable ...

(Date:6/18/2013)... And EMERYVILLE, Calif. , June ... final results today from a Phase 2/3 clinical ... demonstrating a statistically significant improvement in levodopa-induced dyskinesia ... week 8 versus placebo in the Unified Dyskinesia ... formulation of amantadine intended for once-nightly administration that ...

Breaking Medicine Technology:Decision Resources' Market Access Tracker Now Covers the Middle East and Africa 2 Decision Resources' Market Access Tracker Now Covers the Middle East and Africa 3 Omnetics Circular Connectors Offer Both Micro and Nano Interconnects for Highly Portable Electronic Systems, Meeting the Needs of Designers Looking for Size Reduction Options and Cable Flexibility 2 Adamas Pharmaceuticals Presents Positive Phase 2/3 Results For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia (LID) In Parkinson's Disease 2 Adamas Pharmaceuticals Presents Positive Phase 2/3 Results For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia (LID) In Parkinson's Disease 3 Adamas Pharmaceuticals Presents Positive Phase 2/3 Results For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia (LID) In Parkinson's Disease 4 Adamas Pharmaceuticals Presents Positive Phase 2/3 Results For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia (LID) In Parkinson's Disease 5 Adamas Pharmaceuticals Presents Positive Phase 2/3 Results For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia (LID) In Parkinson's Disease 6

[0] Decision Resources' Market Access Tracker Now Covers the Middle East and Africa [0] Omnetics Circular Connectors Offer Both Micro and Nano Interconnects for Highly Portable Electronic Systems, Meeting the Needs of Designers Looking for Size Reduction Options and Cable Flexibility [0] Adamas Pharmaceuticals Presents Positive Phase 2/3 Results For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia (LID) In Parkinson's Disease

... Therapeutics, Inc. (NASDAQ: ECTE ), a company ... wireless, transdermal continuous glucose monitoring system and its Prelude® ... Patrick T. Mooney, M.D., Chairman & CEO of Echo ... Conference. Dr. Mooney will make a presentation ...

... Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL ) today ... operating officer, is scheduled to present a company overview ... York City on Wednesday, December 14th at 1:00 p.m. ... ) To access the live audio webcast ...

Cached Medicine Technology:

Echo Therapeutics to Present at the Oppenheimer Healthcare Conference Rigel to Present at Oppenheimer Annual Healthcare Conference

Lacrimal Cannula, Curved - Open End, 21gSize: 21g x 1-1/2"....

PremierEdge™ Implant Knives....

Interchangeable design allows you to select a single handpiece and change tips during the procedure. Universal connector. Disassembles for easy cleaning. Tips can rotate 360 degrees to re-orient port...

Medicine Products:

Lacrimal Cannula, Curved - Open End.PremierEdge™ Implant Knives Universal I/A handpiece - Titanium (Binkhorst Tip)Universal I/A handpiece - Titanium (Curved Tip, Size: 16g Outer Cannula)